175 related articles for article (PubMed ID: 9229983)
21. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
[TBL] [Abstract][Full Text] [Related]
22. Aprotinin reduces vasoactive medication use during adult liver transplantation.
Findlay JY; Kufner RP
J Clin Anesth; 2003 Feb; 15(1):19-23. PubMed ID: 12657406
[TBL] [Abstract][Full Text] [Related]
23. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
24. [Aprotinin in orthotopic liver transplantation].
García Huete L; Sabaté Pes A
Med Clin (Barc); 1997 Mar; 108(11):439. PubMed ID: 9213647
[No Abstract] [Full Text] [Related]
25. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E
Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867
[TBL] [Abstract][Full Text] [Related]
26. Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin.
Liu CM; Chen J; Wang XH
World J Gastroenterol; 2008 Mar; 14(9):1425-9. PubMed ID: 18322960
[TBL] [Abstract][Full Text] [Related]
27. Aprotinin reduces blood loss and the need for transfusion in orthognathic surgery.
Stewart A; Newman L; Sneddon K; Harris M
Br J Oral Maxillofac Surg; 2001 Oct; 39(5):365-70. PubMed ID: 11601817
[TBL] [Abstract][Full Text] [Related]
28. Randomized, multicentre, double-blind, placebo-controlled trial of the use of aprotinin in the repair of ruptured abdominal aortic aneurysm. On behalf of the Joint Vascular Research Group.
Robinson J; Nawaz S; Beard JD
Br J Surg; 2000 Jun; 87(6):754-7. PubMed ID: 10848853
[TBL] [Abstract][Full Text] [Related]
29. Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled, randomized phase IV study.
Kyriss T; Wurst H; Friedel G; Jaki R; Toomes H
Eur J Cardiothorac Surg; 2001 Jul; 20(1):38-41. PubMed ID: 11423271
[TBL] [Abstract][Full Text] [Related]
30. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
31. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty].
Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M
Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474
[TBL] [Abstract][Full Text] [Related]
32. [Aprotinin in the control of surgical hemorrhage].
Rocha E; Antonio Páramo J; Hermida J
Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
[No Abstract] [Full Text] [Related]
33. [Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin].
Légaré G; Roy A; Dagenais M; Lapointe R; Marleau D; Thuot C
Ann Chir; 1996; 50(8):601-5. PubMed ID: 9035431
[TBL] [Abstract][Full Text] [Related]
34. Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study.
Samama CM; Langeron O; Rosencher N; Capdevila X; Rouche P; Pegoix M; Bernière J; Coriat P
Anesth Analg; 2002 Aug; 95(2):287-93, table of contents. PubMed ID: 12145035
[TBL] [Abstract][Full Text] [Related]
35. Aprotinin reduces blood loss during spinal surgery in children.
Cole JW; Murray DJ; Snider RJ; Bassett GS; Bridwell KH; Lenke LG
Spine (Phila Pa 1976); 2003 Nov; 28(21):2482-5. PubMed ID: 14595168
[TBL] [Abstract][Full Text] [Related]
36. Randomized study of aprotinin effect on transfusions and blood loss in primary THA.
Colwell CW; Chelly JE; Murkin JM; Stevens D; O'Keefe TJ; Hall R; Parvizi J
Clin Orthop Relat Res; 2007 Dec; 465():189-95. PubMed ID: 17767075
[TBL] [Abstract][Full Text] [Related]
37. The intra-operative use of trasylol (aprotinin) in liver transplantation.
Mallett SV; Cox D; Burroughs AK; Rolles K
Transpl Int; 1991 Dec; 4(4):227-30. PubMed ID: 1723874
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
[TBL] [Abstract][Full Text] [Related]
39. Blood conservation in liver transplantation: The role of aprotinin.
Porte RJ; Hendriks HG; Slooff MJ
J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):31S-37S. PubMed ID: 15368204
[No Abstract] [Full Text] [Related]
40. Postoperative use of aprotinin in cardiac operations: an alternative to its prophylactic use.
Ciçek S; Demirkiliç U; Ozal E; Kuralay E; Bingol H; Tatar H; Ozturk OY
J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1462-7. PubMed ID: 8975837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
